The impact of retracted randomised controlled trials on systematic reviews and clinical practice guidelines: a meta-epidemiological study

Author:

Kataoka YukiORCID,Banno MasahiroORCID,Tsujimoto YasushiORCID,Ariie TakashiORCID,Taito ShunsukeORCID,Suzuki TomoharuORCID,Oide ShihoORCID,Furukawa Toshi A.ORCID

Abstract

AbstractObjectivesTo investigate whether and when the correction is done in Systematic Reviews (SRs) and Clinical Practice Guidelines (CPGs) when their included Randomised Controlled Trials (RCTs) have been retracted.DesignA meta-epidemiological study.Data sourcesThe Retraction Watch Database.Eligibility criteria for selecting studiesSRs and CPGs citing the retracted RCTs on Web of Science.Review methodsWe investigated how often the retracted RCTs were cited in SRs and CPGs. We also investigated whether and when such SRs and CPGs corrected themselves by visually inspecting their current web pages. We summarized the proportion of correction and the time from retraction to correction.ResultsWe identified 98 retracted RCTs as well as 360 articles (335 SRs and 25 CPGs) citing them. Among the 360 articles, 157 (44%) were published after the retraction, 203 (56%) were published before retraction. Among 77 articles published citing already retracted RCTs in their evidence synthesis without caution, none corrected themselves after publication. Of 203 articles published before retraction, 149 included RCTs that were later retracted in their evidence synthesis. Among them, one SR was retracted due to plagiarism. Only 5% of SRs (6/130) and 11% of CPGs (2/18) corrected their results.ConclusionsA large number of SRs and CPGs included already retracted RCTs without caution and never corrected themselves. When SRs and CPGs had included RCTs which were later retracted, only a small minority corrected their evidence syntheses. The scientific community, including publishers and researchers, should make systematic and concerted efforts to remove the impact of retracted RCTs.What is already known on this topic-Systematic Reviews (SRs) and Clinical Practice Guidelines (CPGs) aggregating randomised controlled trials (RCTs) are important sources of information for clinical decision making.-There are anecdotal reports of publications citing retracted RCTs and point to the problem of their continued citation after retraction.-However, there are no studies that comprehensively examined the fate of retracted RCTs on SRs and CPGs in their evidence synthesis.What this study adds-A considerable number of SRs and CPGs cited already retracted RCTs and none corrected themselves later.-Only a small minority of SRs (5%, 6/130) and CPGs (11%, 2/18) which cited RCTs that were later retracted corrected their findings after the retraction was announced.-The results indicate that publishers and researchers should make efforts to remove the impact of retracted RCT.

Publisher

Cold Spring Harbor Laboratory

Reference29 articles.

1. Guyatt GH , Rennie D , Meade M , et al. Users’ Guides to the Medical Literature: A Manual for Evidence-Based Clinical Practice. 3rd ed. McGraw-Hill Education 2015.

2. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews

3. Clinical Practice Guidelines We Can Trust

4. When beauty is but skin deep: dealing with problematic studies in systematic reviews

5. Retracted coronavirus (COVID-19) papers – Retraction Watch. https://retractionwatch.com/retracted-coronavirus-covid-19-papers/(accessed 13 Sep 2021).

Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3